Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Citizen Petition Rule On Hold; Pregnancy Label Work Continues

Executive Summary

FDA is no longer pursuing a final rule on limiting the use of citizen petitions

You may also be interested in...



Citizen Petition Proposed Rule Withdrawn; FDA Cites Improved Response Rate

FDA is withdrawing its proposed rule to limit citizen petitions due to improvements in its response rate

Citizen Petition Proposed Rule Withdrawn; FDA Cites Improved Response Rate

FDA is withdrawing its proposed rule to limit citizen petitions due to improvements in its response rate

FDA Seeks Comment On Ad Regs: Can Rx Be More Regulated Than OTCs?

FDA is requesting comment on the legal underpinnings for arguing that promotions of prescription drugs can be more tightly regulated than those for other products

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS039855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel